Skip to main content
. 2014 May 3;14:34. doi: 10.1186/1471-2490-14-34

Table 1.

Biopsy and TRUS results

Biopsy results Previously negative biopsy (%) Active surveillance (%) P-value
% Positive
27/78 (34.6%)
42/49 (85.7%)
0.0001
% Positive in AZ
17/78 (21.8%)
17/49 (34.7%)
0.1492
% TZ involved
8/78 (10.3%)
5/49 (10.2%)
1
% AZ only
1/78 (1.3%)
2/49 (4%)
0.56
% AZ findings changed risk stratification
3/78 (3.8%)
3/49 (6.1%)
0.68
% Only TZ
0/78 (0%)
0/49 (0%)
1
% Cores involved
4.5/26 (17.3%)
3.1/26 (11.9%)
0.0423
Clinically insignificant cancer*
10/27 (37%)
25/49 (51%)
0.3366
Gleason ≥ 7 anywhere
12/27 (44.4%)
12/49 (24.5%)
0.1215
Gleason ≥ 7 in AZ
9/27 (33.3%)
5/49 (10.2%)
0.0273
TRUS results
 
Hypoechoic lesion anywhere
26/78 (33.3%)
12/49 (24.5%)
0.3248
Hypoechoic lesion in AZ
8/78 (10.3%)
0/49 (0%)
0.0228
Hypoechoic lesion in AZ + Cancer in AZ 5/78 (6.4%) 0/49 (0%) 0.1555

*Gleason 6(3 + 3), ≤ 3 cores, ≤ 50% of any core positive.